Background & Aims Nonselective β blockers (NSBBs) reduce portal pressure and the risk for
variceal hemorrhage in patients with cirrhosis. However, development of spontaneous …

Objective Non-selective β-blockers or endoscopic band ligation (EBL) are recommended for
primary prophylaxis of variceal bleeding in patients with oesophageal varices. Additional α …

BACKGROUND & AIMS: We evaluated the gastrointestinal permeability and bacterial
translocation in cirrhotic patients with portal hypertension (PHT) prior to and after non …

Background & Aims We aimed to investigate the impact of sustained virologic response
(SVR) to interferon (IFN)-free therapies on portal hypertension in patients with paired hepatic …

AIM: The aim of this international multicenter study was to evaluate the reliability of Acoustic
Radiation Force Impulse (ARFI) elastography for predicting fibrosis severity, in patients with …

Abstract von Willebrand factor antigen (vWF‐Ag) is elevated in patients with liver cirrhosis,
but the clinical significance is unclear. We hypothesized that vWF‐Ag levels may correlate …

Background & Aims The relationship between acute-on-chronic liver failure (ACLF) and
acute variceal bleeding (AVB) is poorly understood. Specifically, the prevalence and …

METHODS: This is an international cohort study including patients with paired LSM/hepatic
venous pressure gradient (HVPG), LSM≥ 10 kPa, and no previous decompensation. Portal …

Patients admitted with acute variceal bleeding (AVB) and Child‐Pugh C score (CP‐C) or
Child‐Pugh B plus active bleeding at endoscopy (CP‐B+ AB) are at high risk for treatment …

The Billroth III guidelines were developed during a consensus meeting of the Austrian
Society of Gastroenterology and Hepatology (ÖGGH) and the Austrian Society of …